Literature DB >> 33519679

Early-Onset Parkinson Disease Screening in Patients From Nigeria.

Lukasz M Milanowski1,2, Olajumoke Oshinaike3, Benjamin J Broadway2, Jennifer A Lindemann2, Alexandra I Soto-Beasley2, Ronald L Walton2, Rana Hanna Al-Shaikh1, Audrey J Strongosky1, Fabienne C Fiesel2,4, Owen A Ross2,4,5, Wolfdieter Springer2,4, Shamsideen Abayomi Ogun3, Zbigniew K Wszolek1.   

Abstract

Introduction: Nigeria is one of the most populated countries in the world; however, there is a scarcity of studies in patients with age-related neurodegenerative diseases, such as Parkinson disease (PD). The aim of this study was to screen patients with PD including a small cohort of early-onset PD (EOPD) cases from Nigeria for PRKN, PINK1, DJ1, SNCA multiplication, and LRRK2 p.G2019S.
Methods: We assembled a cohort of 109 Nigerian patients with PD from the four main Nigerian tribes: Yoruba, Igbo, Edo, and Hausa. Fifteen cases [14 from the Yoruba tribe (93.3%)] had EOPD (defined as age-at-onset <50 years). All patients with EOPD were sequenced for the coding regions of PRKN, PINK1, and DJ1. Exon dosage analysis was performed with a multiplex ligation-dependent probe amplification assay, which also included a SNCA probe and LRRK2 p.G2019S. We screened for LRRK2 p.G2019S in the entire PD cohort using a genotyping assay. The PINK1 p.R501Q functional analysis was conducted.
Results: In 15 patients with EOPD, 22 variants were observed [PRKN, 9 (40.9%); PINK1, 10 (45.5%); and DJ1, 3 (13.6%)]. Three (13.6%) rare, nonsynonymous variants were identified, but no homozygous or compound heterozygous carriers were found. No exonic rearrangements were present in the three genes, and no carriers of SNCA genomic multiplications or LRRK2 p.G2019S were identified. The PINK1 p.R501Q functional analysis revealed pathogenic loss of function.
Conclusion: More studies on age-related neurodegenerative diseases are needed in sub-Saharan African countries, including Nigeria. Population-specific variation may provide insight into the genes involved in PD in the local population but may also contribute to larger studiesperformed in White and Asian populations.
Copyright © 2021 Milanowski, Oshinaike, Broadway, Lindemann, Soto-Beasley, Walton, Hanna Al-Shaikh, Strongosky, Fiesel, Ross, Springer, Ogun and Wszolek.

Entities:  

Keywords:  DJ1; LRRK2; MLPA; Nigerian population; PINK1; PRKN; Parkinson disease; Sanger sequencing

Year:  2021        PMID: 33519679      PMCID: PMC7841006          DOI: 10.3389/fneur.2020.594927

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  22 in total

1.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

2.  Screening LRRK2 gene mutations in patients with Parkinson's disease in Ghana.

Authors:  Roberto Cilia; Francesca Sironi; Albert Akpalu; Momodou Cham; Fred Stephen Sarfo; Tiziana Brambilla; Alba Bonetti; Marianna Amboni; Stefano Goldwurm; Gianni Pezzoli
Journal:  J Neurol       Date:  2011-08-14       Impact factor: 4.849

3.  Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.

Authors:  Ekaterina Yonova-Doing; Masharip Atadzhanov; Marialuisa Quadri; Paul Kelly; Nyambura Shawa; Sheila T S Musonda; Erik J Simons; Guido J Breedveld; Ben A Oostra; Vincenzo Bonifati
Journal:  Parkinsonism Relat Disord       Date:  2012-03-24       Impact factor: 4.891

4.  The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson's disease.

Authors:  Wei Yi; Emma J MacDougall; Matthew Y Tang; Andrea I Krahn; Ziv Gan-Or; Jean-François Trempe; Edward A Fon
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

Review 5.  LRRK2 G2019S in the North African population: a review.

Authors:  Hani T S Benamer; Rajith de Silva
Journal:  Eur Neurol       Date:  2010-04-23       Impact factor: 1.710

Review 6.  Genetic causes of PD: A pathway to disease modification.

Authors:  M Toffoli; S R L Vieira; A H V Schapira
Journal:  Neuropharmacology       Date:  2020-02-29       Impact factor: 5.250

7.  Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism.

Authors:  Won Tae Yoon
Journal:  Neurol Neurochir Pol       Date:  2017-11-14       Impact factor: 1.621

Review 8.  PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?

Authors:  Dominika Truban; Xu Hou; Thomas R Caulfield; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

9.  A Meta-Analysis of α-Synuclein Multiplication in Familial Parkinsonism.

Authors:  Adam Book; Ilaria Guella; Tara Candido; Alexis Brice; Nobutaka Hattori; Beomseok Jeon; Matthew J Farrer
Journal:  Front Neurol       Date:  2018-12-11       Impact factor: 4.003

Review 10.  Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.

Authors:  Laura L Kilarski; Justin P Pearson; Victoria Newsway; Elisa Majounie; M Duleeka W Knipe; Anjum Misbahuddin; Patrick F Chinnery; David J Burn; Carl E Clarke; Marie-Helene Marion; Alistair J Lewthwaite; David J Nicholl; Nicholas W Wood; Karen E Morrison; Caroline H Williams-Gray; Jonathan R Evans; Stephen J Sawcer; Roger A Barker; Mirdhu M Wickremaratchi; Yoav Ben-Shlomo; Nigel M Williams; Huw R Morris
Journal:  Mov Disord       Date:  2012-09-06       Impact factor: 10.338

View more
  3 in total

Review 1.  Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.

Authors:  Raja Mehanna; Katarzyna Smilowska; Jori Fleisher; Bart Post; Taku Hatano; Maria Elisa Pimentel Piemonte; Kishore Raj Kumar; Victor McConvey; Baorong Zhang; Eng-King Tan; Rodolfo Savica
Journal:  Mov Disord Clin Pract       Date:  2022-09-10

2.  Copy Number Variation in Parkinson's Disease: An Update from Sub-Saharan Africa.

Authors:  Amica C Müller-Nedebock; Morenikeji A Komolafe; Michael B Fawale; Jonathan A Carr; Francois H van der Westhuizen; Owen A Ross; Soraya Bardien
Journal:  Mov Disord       Date:  2021-07-06       Impact factor: 9.698

3.  Systematic Functional Analysis of PINK1 and PRKN Coding Variants.

Authors:  Benjamin J Broadway; Paige K Boneski; Jenny M Bredenberg; Ana Kolicheski; Xu Hou; Alexandra I Soto-Beasley; Owen A Ross; Wolfdieter Springer; Fabienne C Fiesel
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.